Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Tracon Pharmaceuticals
8910 University Center Lane, Suite 700
San Diego, CA 92122
Phone: 858-550-0780
http://www.traconpharma.com/content/

TRACON develops targeted therapies for cancer and age-related macular degeneration. TRACON's current pipeline includes two clinical stage product candidates: TRC105, an anti-endoglin antibody that is being developed for the treatment of multiple solid tumor types, and TRC102, a small molecule that is being developed for the treatment of lung cancer and glioblastoma. Both TRC105 and TRC102 are being developed for treatment in combination with currently available therapies.

Key Contact
Name
Charles P. Theuer
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
09/24/14 $27,000,000 Series B Arcus Ventures
BHP
BioMed Ventures
Brookline Investments
Icon Ventures
Nextech Invest
undisclosed


Featured Reading